Works about MOLNUPIRAVIR

Results: 219
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use.

    Published in:
    Viruses (1999-4915), 2023, v. 15, n. 4, p. 1025, doi. 10.3390/v15041025
    By:
    • Del Borgo, Cosmo;
    • Garattini, Silvia;
    • Bortignon, Carolina;
    • Carraro, Anna;
    • Di Trento, Daniela;
    • Gasperin, Andrea;
    • Grimaldi, Alessandra;
    • De Maria, Sara Giovanna;
    • Corazza, Sara;
    • Tieghi, Tiziana;
    • Belvisi, Valeria;
    • Kertusha, Blerta;
    • De Masi, Margherita;
    • D'Onofrio, Ombretta;
    • Bagaglini, Gabriele;
    • Bonanni, Gabriella;
    • Zuccalà, Paola;
    • Fabietti, Paolo;
    • Tortellini, Eeva;
    • Guardiani, Mariasilvia
    Publication type:
    Article
    21

    Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting.

    Published in:
    Viruses (1999-4915), 2023, v. 15, n. 3, p. 811, doi. 10.3390/v15030811
    By:
    • Mutoh, Yoshikazu;
    • Umemura, Takumi;
    • Nishikawa, Takeshi;
    • Kondo, Kaho;
    • Nishina, Yuta;
    • Soejima, Kazuaki;
    • Noguchi, Yoichiro;
    • Bando, Tomohiro;
    • Ota, Sho;
    • Shimahara, Tatsuki;
    • Hirota, Shuko;
    • Hagimoto, Satoshi;
    • Takei, Reoto;
    • Fukihara, Jun;
    • Sasano, Hajime;
    • Yamano, Yasuhiko;
    • Yokoyama, Toshiki;
    • Kataoka, Kensuke;
    • Matsuda, Toshiaki;
    • Kimura, Tomoki
    Publication type:
    Article
    22

    Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study.

    Published in:
    Viruses (1999-4915), 2023, v. 15, n. 3, p. 704, doi. 10.3390/v15030704
    By:
    • Spiliopoulou, Vassiliki;
    • Ntanasis-Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Gavriatopoulou, Maria;
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Effectiveness of COVID-19 Treatment With Nirmatrelvir–Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes.

    Published in:
    Annals of Internal Medicine, 2023, v. 176, n. 6, p. 807, doi. 10.7326/M22-3565
    By:
    • Bajema, Kristina L.;
    • Berry, Kristin;
    • Streja, Elani;
    • Rajeevan, Nallakkandi;
    • Li, Yuli;
    • Mutalik, Pradeep;
    • Yan, Lei;
    • Cunningham, Francesca;
    • Hynes, Denise M.;
    • Rowneki, Mazhgan;
    • Bohnert, Amy;
    • Boyko, Edward J.;
    • Iwashyna, Theodore J.;
    • Maciejewski, Matthew L.;
    • Osborne, Thomas F.;
    • Viglianti, Elizabeth M.;
    • Aslan, Mihaela;
    • Huang, Grant D.;
    • Ioannou, George N.
    Publication type:
    Article
    39

    Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19: A Target Trial Emulation Study.

    Published in:
    Annals of Internal Medicine, 2023, v. 176, n. 4, p. 505, doi. 10.7326/M22-3057
    By:
    • Wan, Eric Yuk Fai;
    • Yan, Vincent Ka Chun;
    • Mok, Anna Hoi Ying;
    • Wang, Boyuan;
    • Xu, Wanchun;
    • Cheng, Franco Wing Tak;
    • Lai, Francisco Tsz Tsun;
    • Chui, Celine Sze Ling;
    • Li, Xue;
    • Wong, Carlos King Ho;
    • Li, Philip Hei;
    • Cowling, Benjamin John;
    • Hung, Ivan Fan Ngai;
    • Lau, Chak Sing;
    • Wong, Ian Chi Kei;
    • Chan, Esther Wai Yin
    Publication type:
    Article
    40

    Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial.

    Published in:
    Annals of Internal Medicine, 2022, v. 175, n. 8, p. 1126, doi. 10.7326/M22-0729
    By:
    • Johnson, Matthew G.;
    • Puenpatom, Amy;
    • Moncada, Pablo Andrés;
    • Burgess, Lesley;
    • Duke, Elizabeth R.;
    • Ohmagari, Norio;
    • Wolf, Timo;
    • Bassetti, Matteo;
    • Bhagani, Sanjay;
    • Ghosn, Jade;
    • Zhang, Ying;
    • Wan, Hong;
    • Williams-Diaz, Angela;
    • Brown, Michelle L.;
    • Paschke, Amanda;
    • De Anda, Carisa
    Publication type:
    Article
    41
    42
    43
    44

    Healthcare worker access to molnupiravir: A case series.

    Published in:
    PLoS ONE, 2023, v. 18, n. 3, p. 1, doi. 10.1371/journal.pone.0282695
    By:
    • O'Keeffe, Jessica C.;
    • Constable, Meg;
    • Chiang, Janice;
    • Somerville, Margaret;
    • Yerramilli, Arvind;
    • Nolan, Ross;
    • Weeks, Greg;
    • O'Brien, Daniel P.
    Publication type:
    Article
    45
    46
    47
    48
    49
    50

    Molnupiravir.

    Published in:
    Australian Prescriber, 2022, v. 45, n. 2, p. 60, doi. 10.18773/austprescr.2022.014
    Publication type:
    Article